The
development of an automated cell culture system would allow stable and
economical cell processing for wider clinical applications in the field of
regenerative medicine. However, it is crucial to determine whether the cells
obtained by automated culture are comparable to those generated by manual
culture. In the present study, we focused on the primary culture process of
bone marrow stromal cells (BMSCs) for bone tissue engineering and investigated
the feasibility of its automation using a commercially available automated cell
culture system in a clinical setting. A comparison of the harvested BMSCs from
manual and automated cultures using clinically acceptable protocols showed no
differences in cell yields, viabilities, surface marker expression profiles,
and in vivo osteogenic abilities. Cells cultured with this system also did not
show malignant transformation and the automated process was revealed to be safe
in terms of microbial contamination. Taken together, the automated procedure
described in this report provides an approach to clinical bone tissue
engineering.
Website: http://www.arjonline.org/biosciences/american-research-journal-of-biosciences/
Website: http://www.arjonline.org/biosciences/american-research-journal-of-biosciences/
No comments:
Post a Comment